SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 273 filers reported holding SEATTLE GENETICS INC in Q4 2016. The put-call ratio across all filers is 2.22 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $38,446,000 | +60.5% | 196,466 | +39.4% | 0.19% | +32.6% |
Q2 2020 | $23,949,000 | +434.6% | 140,940 | +263.0% | 0.14% | +311.4% |
Q1 2020 | $4,480,000 | +16.5% | 38,829 | +15.4% | 0.04% | +45.8% |
Q4 2019 | $3,844,000 | +787.8% | 33,646 | +563.2% | 0.02% | +700.0% |
Q3 2019 | $433,000 | +30.4% | 5,073 | +6.0% | 0.00% | +50.0% |
Q2 2019 | $332,000 | -6.5% | 4,786 | -1.3% | 0.00% | -33.3% |
Q1 2019 | $355,000 | +46.1% | 4,847 | +54.0% | 0.00% | +50.0% |
Q3 2018 | $243,000 | -83.8% | 3,148 | -86.1% | 0.00% | -90.0% |
Q2 2018 | $1,500,000 | +607.5% | 22,600 | +474.9% | 0.02% | +400.0% |
Q3 2016 | $212,000 | -8.2% | 3,931 | -31.1% | 0.00% | -33.3% |
Q2 2016 | $231,000 | +5.0% | 5,707 | +16.6% | 0.01% | -14.3% |
Q4 2015 | $220,000 | – | 4,894 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |